Michael Gelsomino, MD
Neurological Surgery · Athens, GANPI 1154663599
Payments from drug & device makers
Across 71 payments — averaging $149.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerapedics Inc.$5K
- Globus Medical$4K
- Nevro Corp.$345
- Boston Scientific$181
- Johnson & Johnson$155
- Rapid Medical Ltd$153
- plus $676 from 13 others
What the payments were for
- Consulting fees$1,50014%
- Speaking & faculty fees$1,50014%
- Travel & lodging$4,67644%
- Food & beverage$2,80126%
- Education$1642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerapedics Inc. | 12 | $5,011 |
| Globus Medical(2 entities) | 21 | $4,120 |
| Nevro Corp. | 5 | $345 |
| Boston Scientific | 7 | $181 |
| Johnson & Johnson | 5 | $155 |
| Rapid Medical Ltd | 1 | $153 |
| Stryker | 4 | $146 |
| Integra Lifesciences Corporation | 2 | $116 |
| Trackx Technology, Inc. | 1 | $60 |
| Icotec Medical Inc. | 2 | $58 |
| Coastal Medical Technologies LLC | 2 | $56 |
| Medtronic | 2 | $53 |
| Carlsmed, Inc. | 1 | $38 |
| Novocure Inc. | 1 | $34 |
| Heron Therapeutics, Inc. | 1 | $28 |
| Inspiremd Ltd | 1 | $26 |
| Abbott | 1 | $25 |
| Bioventus LLC | 1 | $19 |
| Biotronik NRO, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,640 in reported general payments places this provider in the 60th percentile of 201 neurological surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 19 | $164 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Athens
- Bryan BarnesAthens$134K
- Harlan BrunerAthens$84K
- Viren VasudevaAthens$22K
- Regis HaidAtlanta$25.5M
- Rishi GuptaMarietta$3.5M
- John CowanRome$3.2M
- Thomas MorrisonAtlanta$2.8M
- Arthur GrigorianAtlanta$2M
- Christopher TomarasAtlanta$1.5M
- Betsy GrunchGainesville$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.